CO5560566A2 - Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson - Google Patents
Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinsonInfo
- Publication number
- CO5560566A2 CO5560566A2 CO04023011A CO04023011A CO5560566A2 CO 5560566 A2 CO5560566 A2 CO 5560566A2 CO 04023011 A CO04023011 A CO 04023011A CO 04023011 A CO04023011 A CO 04023011A CO 5560566 A2 CO5560566 A2 CO 5560566A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- alkoxy
- dialkylamino
- hydroxy
- alkylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
1.- El uso de un compuesto de la fórmula I: en donde:ya sea X es O e Y es N, o X es N e Y es O, R1 es hidrógeno, alquilo de C1-4, cicloalquilo de C3-7, cicloalquilo de C3-7-alquilo de C1-4 o dialquilamino- de C1-4-alquilo de C1-4, R2 es alquilo de C1-4, cicloalquilo de C3-7, benzo[1,3]dioxol-5-ilo, benzo[1,2,5]oxadiazol-5-ilo, benzo[1,2,5]tiadiazol-5-ilo, o un grupo de la fórmula (a): en donde Z es CH o N, R4 es hidrógeno, alquilo de C1-4, alcoxi de C1-4, halógeno, hidroxi, trifluorometilo, dialquilamino de C1-4, alquilamino de C1-4, dialquilamino de C1-4-alquilo de C1-4, alquilamino de C1-4-alquilo de C1-4, dialquilamino de C1-4-alcoxi de C1-4, alquilamino de C1-4-alcoxi de C1-4, dialquilamino de C1-4-alcoxi de C1-4-alquilo de C1-4, alquilamino de C1-4-alcoxi-C1-4-alquilo de C1-4, di(alcoxi de C1-4-alquilo de C1-4)amino, di-(alcoxi de C1-4-alquilo de C1-4)amino-alquilo de C1-4, fenilo, fenoxi, benciloxialquilo de C1-4, alcoxi de C1-4-alquilo de C1-4, alcoxi de C1-4-alcoxi de C1-4-alquilo de C1-4, hidroxialquilo de C1-4, CHO, carboxi, alcoxicarbonilo de C1-4, morfolinometilo, 4-alquilo de C1-4-piperazinilmetilo, piperazinilmetilo, tetrazol-1-ilmetilo, 1-pirrolilmetilo, 3-(dialquilamino de C1-4)-2-hidroxipropoxi-alquilo de C1-4, 3-(dialquilamino de C1-4)-2-hidroxi-propoxi, 3-alquilamino de C1-4-2-hidroxi-propoxi-alquilo de C1-4, 3-alquilamino de C1-4-2-hidroxi-propoxi, 2-hidroxi-3-imidazol-1-il-propoxi-alquilo de C1-4, 2-hidroxi-3-imidazol-1-il-propoxi, 2-hidroxi-3-morfoIin-4-il-propoxi, 2-hidroxi-3-morfoIin-4-iI-propoxi-aIquilo de C1-4,y R5 y R6, independientemente, son hidrógeno, halógeno, hidroxi, alquilo de C1-4, o alcoxi de C1-4, yR3 es hidrógeno, halógeno, alquilo de C1-4, dialquilamino de C1-4-alquilo de C1-4, dialquilamino de C1-4-alcoxi de C1-4, alquilamino de C1-4-alquilo de C1-4, alquilamino de C1-4-alcoxi de C1-4 o alcoxi de C1-4,en la forma de base libre o la forma de sal de adición de ácido farmacéuticamente aceptable, para la fabricación de un medicamento para el tratamiento de la enfermedad de Parkinson.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0119911.6A GB0119911D0 (en) | 2001-08-15 | 2001-08-15 | Organic Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5560566A2 true CO5560566A2 (es) | 2005-09-30 |
Family
ID=9920454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO04023011A CO5560566A2 (es) | 2001-08-15 | 2004-03-12 | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7087756B2 (es) |
| EP (1) | EP1418912B1 (es) |
| JP (1) | JP2005501847A (es) |
| KR (1) | KR20040029429A (es) |
| CN (1) | CN100384418C (es) |
| AR (1) | AR036351A1 (es) |
| AT (1) | ATE355059T1 (es) |
| BR (1) | BR0211903A (es) |
| CA (1) | CA2454762A1 (es) |
| CO (1) | CO5560566A2 (es) |
| DE (1) | DE60218484T2 (es) |
| EC (1) | ECSP044971A (es) |
| ES (1) | ES2282467T3 (es) |
| GB (1) | GB0119911D0 (es) |
| HU (1) | HUP0401325A3 (es) |
| IL (1) | IL160018A0 (es) |
| MX (1) | MXPA04001419A (es) |
| NO (1) | NO20040659D0 (es) |
| PE (1) | PE20030356A1 (es) |
| PL (1) | PL366848A1 (es) |
| PT (1) | PT1418912E (es) |
| RU (1) | RU2004107847A (es) |
| WO (1) | WO2003015780A2 (es) |
| ZA (1) | ZA200400525B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2451057A1 (en) * | 2001-06-14 | 2002-12-27 | Banyu Pharmaceutical Co., Ltd. | Novel isoxazolopyridone derivatives and use thereof |
| EP1745027A4 (en) * | 2004-05-14 | 2009-06-03 | Irm Llc | COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS |
| RU2008135762A (ru) * | 2006-02-16 | 2010-03-27 | Де МакЛин Хоспитал Корпорейшн (US) | Способы и композиции для лечения болезни паркинсона |
| AU2007275301A1 (en) | 2006-07-20 | 2008-01-24 | Amgen Inc. | Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1 |
| FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
| FR2933609B1 (fr) * | 2008-07-10 | 2010-08-27 | Fournier Lab Sa | Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson. |
| US8173670B2 (en) * | 2009-01-13 | 2012-05-08 | Van Andel Research Institute | Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| FR2950053B1 (fr) | 2009-09-11 | 2014-08-01 | Fournier Lab Sa | Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson |
| FR2955110A1 (fr) | 2010-01-08 | 2011-07-15 | Fournier Lab Sa | Nouveaux derives de type pyrrolopyridine benzoique |
| DE102011085038A1 (de) | 2011-10-21 | 2013-04-25 | Tesa Se | Verfahren zur Kapselung einer elektronischen Anordnung |
| CN113845558A (zh) | 2013-09-25 | 2021-12-28 | 范安德尔研究所 | 高效糖皮质激素 |
| KR20170033630A (ko) | 2015-09-17 | 2017-03-27 | (주)다올 | 도로용 경계블럭 |
| RU2019111101A (ru) | 2016-10-14 | 2020-11-16 | Ван Андель Рисерч Инститьют | Структуры и механизм для дизайна высокоактивных глюкокортикоидов |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7602542L (sv) | 1975-03-14 | 1976-09-15 | Sandoz Ag | 3-(alfa-iminobensyl)-4-hydroxi-2(lh)-pyridoner |
| US4064251A (en) * | 1976-06-25 | 1977-12-20 | Sandoz, Inc. | Substituted hydroxy pyridones |
| US4049813A (en) * | 1976-07-15 | 1977-09-20 | Sandoz, Inc. | Substituted isoxazolo pyridinones |
| US4238616A (en) * | 1977-01-19 | 1980-12-09 | Sandoz, Inc. | 3-(Substituted)phenyl-5-(β-hydroxyphenethyl)-N-(alkyl)-isoxazole-4-carboxamides |
| DE2801190A1 (de) * | 1977-01-19 | 1978-07-20 | Sandoz Ag | 3-(alpha-iminobenzyl)-4-hydroxy-2(1h)- pyridon-derivat |
| US4113727A (en) * | 1977-04-26 | 1978-09-12 | Sandoz, Inc. | Process for the preparation of substituted isoxazolo[4,5-c]pyridin-4-(5H)-ones |
| CA2451057A1 (en) * | 2001-06-14 | 2002-12-27 | Banyu Pharmaceutical Co., Ltd. | Novel isoxazolopyridone derivatives and use thereof |
-
2001
- 2001-08-15 GB GBGB0119911.6A patent/GB0119911D0/en not_active Ceased
-
2002
- 2002-08-13 AR ARP020103046A patent/AR036351A1/es unknown
- 2002-08-14 US US10/486,569 patent/US7087756B2/en not_active Expired - Fee Related
- 2002-08-14 MX MXPA04001419A patent/MXPA04001419A/es unknown
- 2002-08-14 PE PE2002000734A patent/PE20030356A1/es not_active Application Discontinuation
- 2002-08-14 KR KR10-2004-7002124A patent/KR20040029429A/ko not_active Application Discontinuation
- 2002-08-14 JP JP2003520739A patent/JP2005501847A/ja not_active Withdrawn
- 2002-08-14 CA CA002454762A patent/CA2454762A1/en not_active Abandoned
- 2002-08-14 RU RU2004107847/15A patent/RU2004107847A/ru not_active Application Discontinuation
- 2002-08-14 CN CNB028159268A patent/CN100384418C/zh not_active Expired - Fee Related
- 2002-08-14 BR BR0211903-0A patent/BR0211903A/pt not_active IP Right Cessation
- 2002-08-14 AT AT02772157T patent/ATE355059T1/de not_active IP Right Cessation
- 2002-08-14 PL PL02366848A patent/PL366848A1/xx not_active Application Discontinuation
- 2002-08-14 EP EP02772157A patent/EP1418912B1/en not_active Expired - Lifetime
- 2002-08-14 WO PCT/EP2002/009134 patent/WO2003015780A2/en active IP Right Grant
- 2002-08-14 PT PT02772157T patent/PT1418912E/pt unknown
- 2002-08-14 DE DE60218484T patent/DE60218484T2/de not_active Expired - Lifetime
- 2002-08-14 HU HU0401325A patent/HUP0401325A3/hu unknown
- 2002-08-14 ES ES02772157T patent/ES2282467T3/es not_active Expired - Lifetime
- 2002-08-14 IL IL16001802A patent/IL160018A0/xx unknown
-
2004
- 2004-01-23 ZA ZA200400525A patent/ZA200400525B/en unknown
- 2004-02-03 EC EC2004004971A patent/ECSP044971A/es unknown
- 2004-02-13 NO NO20040659A patent/NO20040659D0/no not_active Application Discontinuation
- 2004-03-12 CO CO04023011A patent/CO5560566A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60218484T2 (de) | 2007-11-15 |
| PT1418912E (pt) | 2007-05-31 |
| MXPA04001419A (es) | 2004-05-27 |
| PE20030356A1 (es) | 2003-05-14 |
| HUP0401325A2 (hu) | 2004-10-28 |
| EP1418912B1 (en) | 2007-02-28 |
| JP2005501847A (ja) | 2005-01-20 |
| NO20040659L (no) | 2004-02-13 |
| WO2003015780A8 (en) | 2004-05-21 |
| CA2454762A1 (en) | 2003-02-27 |
| RU2004107847A (ru) | 2005-05-10 |
| GB0119911D0 (en) | 2001-10-10 |
| KR20040029429A (ko) | 2004-04-06 |
| ZA200400525B (en) | 2005-04-01 |
| NO20040659D0 (no) | 2004-02-13 |
| CN100384418C (zh) | 2008-04-30 |
| CN1635889A (zh) | 2005-07-06 |
| ES2282467T3 (es) | 2007-10-16 |
| BR0211903A (pt) | 2004-09-21 |
| US20040248893A1 (en) | 2004-12-09 |
| EP1418912A2 (en) | 2004-05-19 |
| WO2003015780A2 (en) | 2003-02-27 |
| PL366848A1 (en) | 2005-02-07 |
| DE60218484D1 (de) | 2007-04-12 |
| ECSP044971A (es) | 2004-03-23 |
| US7087756B2 (en) | 2006-08-08 |
| ATE355059T1 (de) | 2006-03-15 |
| AR036351A1 (es) | 2004-09-01 |
| IL160018A0 (en) | 2004-06-20 |
| HUP0401325A3 (en) | 2005-09-28 |
| WO2003015780A3 (en) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5560566A2 (es) | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson | |
| SE0203754D0 (sv) | New compounds | |
| PE20061164A1 (es) | Piperazin-piperidinas sustituidas con pirazinilo con actividad antagonista de cxcr3 | |
| BRPI0413232A (pt) | novos compostos tendo atividade inibitória contra os trasnportadores dependentes de sódio | |
| PE20061305A1 (es) | Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas | |
| CO5590929A2 (es) | Derivados de acetileno que tienen actividad antagonica de mgiur5 | |
| DE60107820D1 (de) | Neue verwendung von phenylheteroalkylamin-derivaten | |
| DE69823648D1 (de) | 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4) | |
| DE60236719D1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| PE20050420A1 (es) | Fenacilo 2-hidroxi-3-diaminoalcanos | |
| BR0313407A (pt) | Novo uso de derivados de benzotiazol | |
| ATE106885T1 (de) | Substituierte harnstoffverbindungen, ihre herstellung und verwendung. | |
| SE0301232D0 (sv) | Novel use | |
| NZ514542A (en) | Vasopressin antagonists for the treatment of pulmonary hypertension | |
| WO2004017977A3 (en) | 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors | |
| RU2004117543A (ru) | Амиды антраниловой кислоты и их применение в качестве ингибиторов тирозинкиназного рецептора фактора роста сосудистого эндотелия (vegf) | |
| AR035451A1 (es) | Derivados de beta-carbolina, su uso para la fabricacion de un medicamento para el tratamiento de la depresion, ansiedad y desordenes bipolares, una composicion farmaceutica y una combinacion. | |
| ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| JP2005501847A5 (es) | ||
| TW200505446A (en) | Inhibitor of cox | |
| DE60127535D1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
| WO2002074777A3 (en) | Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity | |
| NO961077D0 (no) | Substituerte benzoltienylpiperaziner, deres anvendelse som medikamenter og fremgangsmåter for fremstilling | |
| PT1463504E (pt) | Composicoes compreendendo epotilonas e sua utilizacao para o tratamento de sindroma carcinoide | |
| SG148023A1 (en) | New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |